Several cyclic oligodeoxynucleotides with different base composition and size have been prepared from 5',3'-unprotected linear precursors, using a bifunctional phosphorylating reagent. The final deprotected ollgomers have been characterized by 1 H-and 31 P-NMR. The present procedure is particularly useful for millimolar scale syntheses.
INTRODUCTION
For a long time, studies of cyclic oligonucleotides have been confined to those isolated, in small amounts, from homopolymenzation reactions* 1 ' . Although NMR and CD investigations had supported the idea that these compounds could be good models for the loop portions of transfer and ribosomal nucleic acids* 2 ', efficient synthetic protocols were developed only after the discovery of important biological activity of c(ApUp), c(UpUp)< ' as well as solid-phase syntheses* 7 ' have recently been reported, which follow the reaction sequence summarized in Scheme 1 for a protected dimer. These methods allow the preparation of 'medium-sized' ollgomers (8-10 nucleotides) and also open the way to the synthesis of model compounds (such as 'lazo') involved in the splicing process.
We have previously reported' 8 ' a one-pot method, (Scheme 2), for the synthesis of dimers from open chain precursors, which makes use of the bifunctional phosphorylating reagent 2-chlorophenyl-bis-O,O-(l-benzotnazolyl)phosphate (diOBT).
The scope and limitations of this procedure have now been tested in the synthesis of several cyclic oligodeoxynucleotides having different base composition and size.
RESULTS AND DISCUSSION
Since we are interested in dimers and trimers for physicochemical and biological activity studies, larger cycles were only prepared to test the possible limitations of the method when applied to longer substrates.
Synthesis of the open chain precursors
The linear dimers and trimers were obtained according to published procedures' 9 ', following the reaction sequences reported in Scheme 3. This method exploits the well known' 9 ' ability of the intermediates like 2 to react selectively at the 5' position with nucleosides having unprotected 5'-and 3'-OH groups. The DMTr group was removed with benzenesulphoruc acid. Compounds 4, 5, 7 , and 8 were purified by flash chromatography on silica gel.
Longer open chain ohgodeoxyadenyhc compounds were obtained according to the reaction sequence outlined in Scheme 4. This method may be used only if the dimer 11 reacts with the 3' phosphorylated intermediates (i. t.10) mainly at the 5'-OH group. T.l.c. analysis of the final reaction mixtures showed one main product, traces of higher running materials and the lower running unreacted 11. By analogy with what was observed' 9 ' in the dimer case, the possible by-products in the synthesis of 12 are 76a and 17 (Figure 1 ). The tetramer 76a results from the reaction of the 3'-OH group of 77, whereas the hexamer 77may be formed toward the end of the reaction, when the concentration of 77 becomes low compared to that of the newly formed 12. Thus a quite large excess of 77 was used to minimize its formation. On the other end, the amount of 76a vs. 12, which reflects the intrinsic reactivities of the 3'-and 5'-OH groups respectively, cannot be affected without changing the reaction conditions. In order to confirm that the dimer 77 reacts preferentially with its 5'-OH group (Scheme 4) the 'wrong' tetramer 76£ was prepared by treating the dimer 9 with 0.55 equivalents of diOBT. Products like 76 and 77 have a 3'-3' linkage which can be easily distinguished from the normal 3'-5' intemucleotidic bond by 3I P-NMR after deprotection' 9 '. Thus, the tetramer 16b was detritylated, cyclized and deprotected in exactly the same way as the other compounds. As reported below, the final results were in agreement with the structures reported in Scheme 4 for 12 and 14.
The linear ollgomers can also be prepared by following the method described by Marugg et al. ' 9 ', which makes use of a 3' protecting group (tevulinoyl) which can be removed selectively at the end of die elongation stage.
Cyclization reaction
This step was performed by treating a pyndine solution of the linear precursors with a 0.2 M solution of diOBT in dioxane (Scheme 5).
For its successful outcome a few aspects must be considered: -since diOBT is very reactive either II and 777 can form as reactive intermediates, both giving the desired cyclic product; -formation of /, which is wasteful, is greatly reduced by adding the diOBT solution portionwise; -at high dilution (6x 10~4 M) the water still present in 'dry' pyndine, which reacts with diOBT, cannot be neglected in calculating the total amount of phosphorylating agent required; -the rate of ring closure of // and /// is very important; preliminary experiments showed that the reaction occurs in less than 20 minutes for 0 ^n <,2.
Accordingly, the best procedure was to add the diOBT solution dropwise in three batches: first a volume corresponding to the water content + 20% of the total amount needed for reacting A; after 15 minutes and t.l.c. analysis a volume corresponding to about 70% of unreacted A and finally, after t.l.c. control, the quantity necessary to convert the unreacted starting material. In this way the formation of diphosphorylated derivatives / is greatly reduced and the cyclic products are obtained in good yields. adding 10 equivalents of N-methyl-imidazole and the final product was obtained in very good yield If the reaction has to be run on a 'large' scale (> 0.5 mmol), it is possible to improve the method by reducing the amount of solvent. A portion of a 0.1 M solution of the substrate was added to a small volume of pyndine so that its concentration in the reaction medium was 6x 10~4 M. The diOBT solution was then added dropwise in a quantity corresponding to the water present in the starting pyridine (see above) plus the added substrate. After 20 minutes the same volume, of substrate solution was added again, followed by the corresponding amount of the phosphorylating reagent; the procedure was repeated every 20 minutes, until the starting material was exhausted.
Doubtless, this 'stop and go' method is convenient only when the cyclization reaction is fast (^20'). This modified protocol was tested in the synthesis of c[d(Ap>2] and c[d(Gp)2] on a 1 mmol scale with satisfactory results. Table 1 reports the yields of the protected cyclic oligodeoxynucleotides obtained with the standard (S) and modified (M) procedures.
Deprotection and characterisation
The cyclic compounds were deprotected by first treating with N',N l ,N 3 ,N 3 -tetramethylguanidinium-syn-pyridine-2-carbaldoximate followed by concentrated aqueous ammonia at 50°C. The crude materials were purified by ion-exchange chromatography, giving the unprotected cycles in 70-80% yields (HPLC purity s95%). 'H and 31 P-NMR and, in some instances, FAB-MS spectroscopies were used to characterize the final compounds. (Table 3 of experimental).
Homo-ohgomers.
'H-NMR spectra, in agreement with the symmetrical structure of these molecules, showed only one set of resonance for each type of proton present in the monomeric unit* 6 -710 *, except for the 'wrong' tetramer 18 obtained from the linear precursor 16b. Accordingly, just one peak was present in the corresponding 3I P-NMR (H-decoupled) spectra, with the exception of the unsymmetrical tetramer 18 (Figure 2 ), which gave three well separated signals (ratio 1:2:1 corresponding to one 3'-3', two 3'-5' and one 5'-5' phosphodiester bonds). This finding is important because it confirms the formation of all 3'-5' internucleotidic linkages in the synthesis of the linear tetra-and hexanucleotides in Scheme 4, since the unprotected cycles obtained from them gave only one 3I P resonance.
In Figure 2 the 3I P-NMR spectra of both symmetrical and unsymmetrical 18 cyclic tetradeoxyadenylic acids (Na salts) are reported.
Hetero-oligomers. In the 'H-NMR spectra the signals corresponding to the different protons of each mononucleotide were well separated in the low field region, whereas some overlapping occurred in the 4', 5' and 2' regions.
The 3I P-NMR spectra of all four compounds presented only one resonance instead of the two or three signals expected for these unsymmetnca] cycles. This is likely due to a small difference (less than 0.2 ppm) of the chemical shift values. In conclusion the present methodology compares well with those recently pubblished (6>7) for the synthesis of cyclic oligonucleotides and it is especially convenient when the final products are required in millimolar amounts. 1) . N-methylimidazole was distilled under reduced pressure All liquids were stored under argon over 4 A molecular sieves Triethylammonium bicarbonate (TEAB) buffer was prepared by passing CO? gas through a 0°C cooled solution of 2 M triethylamine in water until a neutral solution was obtained.
EXPERIMENTAL

General methods and materials
Pyndine, dioxane, CH 2 C1 2 , MeOH, EtOH, NHtOH, CH 3 CN and other solvents were purchased from Carlo-Erba. Synthesis of partially protected linear dimers (5) and trimers (« As outlined in Scheme 3 these compounds were obtained from the corresponding 4 and 7, which, in turn, were prepared by a well established method (9) . Detritylation was earned out by treating 1 mmol of 4 or 7 dissolved in 25 ml of CH 2 Cl 2 /MeOH 7/3 (V/V) at 0°C with a prechilled solution of benzenesulphonic acid (4% w/w) in the same solvent system. After stirring for 10' at 0°C the solution was quenched with 40 ml of 5% NaHCO 3 and diluted with 40 ml of CH 2 C1 2 . The organic layer was washed with 40 ml of water, dried over Na 2 SO 4 and concentrated. The crude product was precipitated with petroleum ether (40-60°) and purified by flash chromatography on silica gel. In the case of d(TpT), which is rather soluble in water, quenching was carried out using a few drops of 25% NH 4 OH. The reaction mixture was concentrated, suspended in CH 2 C1 2 containing 10% MeOH and applied to a silica gel column.
The yield of pure dimers 5 and trimers 8, based on the starting nucleosides 1 are reported in Table 2 . The compounds were prepared following the reaction sequence outlined in Scheme 4. 2.7 g (2 mmol) of dimer 9 were coevaporated three times with anhydrous pyridine and dissolved in 5 ml of the same solvent. 12 ml of 0.2 M diOBT solution were added under argon to the stirred solution. After 15', 3.2 g (3 mmol) of dimer 11, dried as above, were dissolved in 15 ml of anhydrous pyridine and added to the reaction mixture. After stirring for 60' t.l.c. analysis (CH 2 C1 2 / MeOH 9/1) showed that intermediate 10 (baseline material) had disappeared. The reaction mixture was treated with a few ml of 1 M TEAB, diluted with 100 ml of CH 2 C1 2 and washed with 50 ml of 1M TEAB, then with 50 ml of water. The organic layer was dried (Na 2 SO 4 ), concentrated to a small volume and the crude material precipitated by adding petroleum ether (40-60° 3I P-NMR spectra of symmetric and dissimmetnc cyclic tetra-adenylic acids (0.65 mmol) of 12 were detritylated as previously descnbed to give 1.34 g of pure 13 (72% yield). Following the same overall procedure 1.78 g (68% yield) of hexamer 15 were obtained from 1.9 g of tetramer 12.
Synthesis of tetramer 16b 1.37 g (1 mmol) of dimer 9, dried by coevaporation with anhydrous pyridine, were dissolved in 4 ml of the same solvent and treated with 2.75 ml of 0.2 M diOBT solution whilst stirring; after 2 hours the reaction was quenched with 1 M TEAB and worked up as usual to give 0.95 g of 16b (67% yield).
Cyclization procedure
As an example, the synthesis of fully protected c[d(C DPA pC DPA p)] is reported. 600 mg (0.59 mmol) of dimer d(C DPA C DPA ) were coevaporated 3 times with anhydrous pyridine and dissolved in 100 ml of the same solvent, which contained about 0.3 mmol of water. A gas tight syringe was charged with 6 ml of 0.2 M diOBT solution, corresponding to 1.3 equivalents with respect (8) B,
All nucleosides are protected as in Table 1 to the sum of the reacting species (0.59 + 0.3) and 3.5 ml were added dropwise (over 15') to the above solution. After 15' t.l.c. analysis (CH 2 Cl 2 /MeOH 9/1) showed the presence of: about 70% of the starting material (R f =0.49), two products with R f =0.61 and 0.76 and baseline material. 2 ml of the phosphorylating reagent were then added over 15'; a small amount of the starting dimer, detected (t.l.c.) 15' after the end of the addition, disappeared completely by adding another 0.5 ml of diOBT solution. The reaction mixture was quenched with 0.5 ml of 1 M TEAB and pyridine was removed under reduced pressure. The oily residue, dissolved in 80 ml of CH2CI2 was washed with 30 ml of water, dried with Na 2 SO 4 and concentrated to an oily residue that was finally triturated with petroleum ether 40-60°. The precipitate was purified by flash chromatography on silica gel, eluting with CH 2 G 2 /MeOH 95/5. The two main products (Rf=0.76 and 0.61) were obtained in an overall yield of 80%. Their likely identification as diasteroisomers at phosphorus was confirmed by finding that after deprotection they gave the same final compound (HPLC analysis). This procedure was applied in all cases, including the cyclization of hexamer 15 in the presence of 10 equivalents of N-methyl-imidazole. It is important to underline that the progress of the reaction is easily monitored by t.l.c. analysis, since the linear starting oligomers always have lower R f values than the corresponding cyclic products. Hence, the amount of unreacted substrate can be estimated after each addition of the phosphorylating reagent, whose total amount can be dosed accordingly.
Modified cyclization procedure 1.06 g (1 mmol) of d(A DPA A DPA ), after coevaporation with anhydrous pyridine, were dissolved in the same solvent to give 9 ml of solution which was loaded into a gas tight syringe (solution A).
8 ml of 0.2 M diOBT (solution B) were loaded into a syringe and both syringes were applied, through a rubber stopper, to a flask containing 25 ml of anhydrous pyridine (residual water content of about 0.1 mmol). Under stirring, 1.5 ml of solution A were added at once followed by 1.7 ml of solution B (dropwise addition). After 15' t.l.c. analysis (CH 2 Cl 2 /Me0H 9/1) showed the presence of some linear dimer (R f =0.56) and two products with R f =0.73 and 0.86. Upon addition of 0.4 ml of solution B the linear dimer was converted into the two higher running compounds. 1.5 ml of solution A were then added followed by 1.1 ml of solution B. After 15' t.l.c. showed only the two higher running products and a shadow of baseline material. The tandem addition of solutions A and B was repeated at 20' intervals. The final reaction mixture was worked up as previously described to give the 2 diastereoisomers of the cyclic compound in an overall yield of 55% .
Deprotection and purification of the cyclic oligonucleotides
The fully protected ohgomer: [hexamer (0.18 mmol), tetramers (0.27 mmol), trimers (0.36 mmol) and dimers (0.54 mmol)] was dissolved in a solution of 5>n-pyridine-2-carboxaldoxime (1 64 g, 13.5 mmol) and 1,1,3,3-tetramethylguanidine (1.4 ml, 11 mmol) in 27 ml of dry pyridine. After 24 hours at room temperature, 80 ml of 25% NH4OH were added and the resulting solution was kept at 50°C for 48 hours in a securely sealed flask. The reaction mixture was concentrated to small volume, coevaporated several times with water and washed with ethyl ether (3 x 15 ml). Water was removed by repeated coevaporation with absolute ethanol, the residual thick oil was dissolved in hot ethanol (50-60°C) and acetone was added slowly under shaking. The crude product was obtained as an almost colorless powder, which was applied to a column (15X2.5 cm) of DEAE-Sephacell and eluted with a linear gradient of TEAB buffer from 0.05 M to 1.0 -2.0 M depending upon the size of the oligomer. After HPLC analysis (column: spherisorb Qg, eluant: gradient from 0 to 30% of CH 3 CN in 0.05M of KH 2 PO 4 pH 4.5) fractions with purity > 93% were pooled and evaporated several times with water to remove the TEAB buffer. The triethylammonium counterions were repla ced by either ammonium (repeated coevaporation with con centrated ammonia) or sodium (10X 1.5 cm column of Dowex 50 W (Na) resin). The final compounds were characterized by 'H-NMR (400 M), 3I P-NMR (80 M) and MS spectroscopy (FAB mode).
